Christopher C Porter Selected Research

1,25-dihydroxyvitamin D3-3-bromoacetate

3/2016

Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher C Porter Research Topics

Disease

17	Neoplasms (Cancer) 09/2022 - 02/2003
15	Leukemia 01/2022 - 12/2013
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2004
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 12/2013
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2019
2	Thrombocytopenia (Thrombopenia) 10/2019 - 05/2015
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2017 - 09/2015
2	Lung Neoplasms (Lung Cancer) 12/2013 - 08/2012
2	Human Influenza (Influenza) 01/2004 - 02/2003
1	Cardiomyopathies (Cardiomyopathy) 09/2022
1	2-Hydroxyglutaricaciduria 09/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2022
1	Inflammation (Inflammations) 08/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Obesity 01/2022
1	Multiple Sclerosis 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Hepatitis 01/2021
1	Hypersensitivity (Allergy) 11/2019
1	Down Syndrome (Down's Syndrome) 11/2019
1	Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome) 01/2019
1	Second Primary Neoplasms (Neoplasms, Second) 01/2018
1	Osteopetrosis 01/2017
1	Chronic Granulomatous Disease 01/2017
1	Triple Negative Breast Neoplasms 03/2016
1	Disease Progression 03/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2014
1	Breast Neoplasms (Breast Cancer) 05/2014
1	Adenocarcinoma 08/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2012
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 02/2009
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2009
1	Carcinogenesis 12/2005
1	Infections 02/2003

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2022 - 09/2014
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2008
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 12/2013
4	adavosertibIBA 01/2018 - 12/2013
3	Interleukin-12 (IL 12)IBA 01/2022 - 01/2019
3	CytokinesIBA 01/2021 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	AntigensIBA 01/2022 - 01/2004
2	LigandsIBA 01/2022 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2020 - 09/2014
2	InterferonsIBA 11/2019 - 01/2017
2	CalcineurinIBA 01/2019 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2013
2	AntimetabolitesIBA 09/2015 - 12/2013
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2004 - 02/2003
1	alpha-hydroxyglutarateIBA 09/2022
1	AnthracyclinesIBA 09/2022
1	Interleukin-18 (Interleukin 18)IBA 08/2022
1	Interleukin-13IBA 08/2022
1	Single-Chain AntibodiesIBA 01/2022
1	Thrombopoietin (c-mpl Ligand)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2021
1	ChemokinesIBA 01/2021
1	Biological ProductsIBA 01/2020
1	Interferon Type IIBA 11/2019
1	Adenosine Monophosphate (AMP)IBA 10/2019
1	Uric Acid (Urate)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2018
1	olaparibIBA 10/2017
1	Antineoplastic Agents (Antineoplastics)IBA 03/2016
1	1,25-dihydroxyvitamin D3-3-bromoacetateIBA 03/2016
1	NucleotidesIBA 05/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2014
1	Tyrosine Kinase InhibitorsIBA 09/2014
1	Dasatinib (BMS 354825)FDA Link 09/2014
1	TankyrasesIBA 08/2012
1	ErbB Receptors (EGF Receptor)IBA 08/2012
1	nutlin 3IBA 07/2012
1	Vincristine (Oncovin)FDA LinkGeneric 02/2009
1	Antifungal AgentsIBA 02/2009
1	Voriconazole (Vfend)FDA LinkGeneric 02/2009
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2005
1	DNA (Deoxyribonucleic Acid)IBA 12/2005
1	Hemagglutinins (Hemagglutinin)IBA 01/2004

Therapy/Procedure

9	Therapeutics 01/2022 - 02/2013
4	Drug Therapy (Chemotherapy) 01/2022 - 12/2013
3	Immunotherapy 01/2022 - 10/2020
1	Precision Medicine 01/2022
1	Rejuvenation 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Maintenance Chemotherapy 01/2004